Screener
Vir Biotechnology, Inc. VIR Q1 2026 earnings
Reported May 6, 2026 · After market close
Revenue-$29.0KMiss by $55.5M
EPS-$0.85Miss by $0.84
Revenue estimate$55.5M
EPS estimate-$0.01
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$865.1K
EPS estimate-$0.74
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Vir Biotechnology, Inc. report Q1 2026 earnings?
- Vir Biotechnology, Inc. (VIR) reported Q1 2026 earnings on May 6, 2026 after market close.
- What were Vir Biotechnology, Inc.'s Q1 2026 revenue and EPS?
- Vir Biotechnology, Inc. reported revenue of -$29.0K and eps of $-0.85 for Q1 2026.
- Did Vir Biotechnology, Inc. beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $55.5M by $55.5M. EPS missed the consensus estimate of $-0.01 by $0.84.
- How did Vir Biotechnology, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 101.6% from $1.8M a year earlier and eps grew 3.4% from $-0.88.
- Where can I find Vir Biotechnology, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-031273) and the 10-Q periodic report (0001628280-26-031471) directly on SEC EDGAR. The filing index links above go to sec.gov.
